Pulmonx Corp (LUNG) Live Share Price, Invest From India

Pulmonx Corp Stock Performance

as on February 7, 2026 at 7:59 am IST

Day's Low
Day's High
$1.45
Day's Price Range
$1.51
$1.50
3.33%
Downside
0.67%
Upside
52 Week's Low
52 Week's High
$1.31
52-Week Price Range
$9.37
$1.50
12.67%
Downside
524.67%
Upside

Pulmonx Corp share price movements today

Previous Close: $1.45
Open: $1.48
Volume: 672.2K
Day's Low - High: $1.45 - $1.51
52 Week Low - High: $1.31 - $9.37

Pulmonx Corp Historical Returns

1 Month Return: -32.13 %
3 Month Return: -21.87 %
1 Year Return: -77.38 %
3 Year Return: -83.68 %
5 Year Return: -97.51 %

Pulmonx Corp Stock Fundamentals & Key Indicators

Check Pulmonx Corp market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$73.8M

EPS (TTM)

-1.4633

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-4.95

Industry PE ratio

-1.6902868852459016

PEG Ratio

EBITDA

-56.1M

Revenue (TTM)

91.7M

Profit Margin

-61.91%

Return On Equity TTM

-73.73%

Pulmonx Corp Stock Valuation

Track how Pulmonx Corp P/E has moved over time to understand its valuation trends.

Pulmonx Corp in the last 5 years

Overview
Trends

Lowest (-31.99x)

September 30, 2021

Today (-4.95x)

February 7, 2026

Industry (-1.69x)

February 7, 2026

Highest (-1.48x)

September 30, 2025

LowHigh

Today’s Price to Earnings Ratio: -4.95x

Pulmonx Corp vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Pulmonx Corp with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Pulmonx Corp	BUY	$73.8M	-97.51%	-4.95	-61.91%
Boston Scientific Corp.	BUY	$138.7B	95.76%	50.03	14.43%
Stryker Corporation	BUY	$136.5B	50.05%	46.97	12.07%
Medtronic Plc	BUY	$129.1B	-13.09%	27.28	13.71%
Edwards Lifesciences Corp.	BUY	$49.1B	-7.51%	36.83	23.25%

See all

Stock Returns calculator for Pulmonx Corp Stock including INR - Dollar returns

The Pulmonx Corp stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Pulmonx Corp investment value today

Current value as on today

₹26,147

Returns

₹73,853

(-73.85%)

Returns from Pulmonx Corp Stock

₹77,376 (-77.38%)

Dollar Returns*

₹3,522 (+3.52%)

Analyst Recommendation on Pulmonx Corp Stock

Based on 11 analysts

BUY

81.82%

Buy

18.18%

Hold

0.00%

Sell

Based on 11 analysts, 81.82% of analysts recommend a 'BUY' rating for Pulmonx Corp. Average target price of $5.75

Pulmonx Corp Share Price Target

Get share price movements and forecasts by analysts on Pulmonx Corp.

What analysts predicted

73.91%UPSIDE

Target Price

$5.75

Current Price

$1.5

Analyzed by

11 Analysts

Target

$5.75

Pulmonx Corp target price $5.75, a slight upside of 73.91% compared to current price of $1.5. According to 11 analysts rating.

Pulmonx Corp Stock’s Investor Sentiment and Interest

Search interest for Pulmonx Corp Stock has decreased by -62% in the last 30 days, reflecting a downward trend in search activity.

Time period: January 10, 2026 to February 9, 2026

Change:-62% versus previous 30 day period

Pulmonx Corp Quarterly Profit & Loss

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Total Revenue	17	17	19	18	20	20	23	22	23	21
Gross Profit	12	13	14	13	15	15	17	16	17	16
Operating Income	-16	-15	-13	-14	-15	-14	-13	-14	-14	-14
EBITDA	-14	-13	-12	-12	-13	-12	-13	-14	-13	-12
Interest Expense	0	0	0	0	0	0	0	0	0	0
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-16	-14	-13	-13	-15	-13	-13	-14	-14	-13
Income Tax Expense	0	0	0	0	0	0	0	0	0	0
Net Income	-16	-14	-13	-13	-15	-14	-13	-14	-15	-13
Net Profit Margin	-94.19%	-84.33%	-72.04%	-72.92%	-73.74%	-69.38%	-55.44%	-64.11%	-63.59%	-64.91%

Pulmonx Corp Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	0	0	-	20	32	32	48	53	68	83
Gross Profit	0	0	-	12	22	21	35	39	50	62
Operating Income	-2	-2	-5	-15	-17	-32	-47	-58	-61	-57
EBITDA	-	-	-	-15	-16	-28	-46	-55	-55	-50
Interest Expense	-	-	-	2	2	3	0	1	3	3
Depreciation	-	-	-	0	0	0	0	1	1	1
Income Before Tax	-2	-2	-5	-18	-20	-32	-48	-58	-60	-55
Income Tax Expense	-	-	-	0	0	0	0	0	0	0
Net Income	-2	-2	-5	-18	-20	-32	-48	-58	-60	-56
Net Profit Margin	-14398.30%	-31539.27%	0.00%	-92.38%	-63.52%	-98.47%	-100.51%	-109.80%	-88.60%	-67.30%

Pulmonx Corp Quarterly Cash Flow

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Net Income	-14	-13	-13	-15	-14	-13	-14	-15	-13
Operating Cash Flow	-8	-8	-11	-5	-7	-6	-13	-3	-8
Investing Cash Flow	0	-2	-2	0	6	14	16	5	8
Financing Cash Flow	0	0	0	0	0	0	0	0	0
Change in Cash	-6	-11	-13	-6	0	7	3	0	1

Pulmonx Corp Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-2	-5	-18	-20	-32	-48	-58	-60	-56
Operating Cash Flow	-2	-4	-18	-20	-30	-41	-45	-37	-31
Investing Cash Flow	0	0	0	-14	12	-46	-4	-2	17
Financing Cash Flow	1	5	12	45	234	4	2	21	1
Change in Cash	0	0	-5	10	217	-83	-46	-18	-12

Global Institutional Holdings in Pulmonx Corp

Funds	Holdings
BlackRock Inc	6.6%
Vanguard Group Inc	5.63%
Millennium Management LLC	2.86%
Deutsche Bank AG	2.76%
Silvercrest Asset Management Group LLC	2.28%

See all

Insights on Pulmonx Corp

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, -15.17M → -13.95M (in $), with an average increase of 8.7% per quarter
NO EFFECT
Against Peers
In the last 3 years, Boston Scientific Corp. has given 23.1% return, outperforming this stock by 105.8%
NO EFFECT
Against Peers
In the last 1 year, Medtronic Plc has given 14.3% return, outperforming this stock by 91.7%
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 23.85M → 21.50M (in $), with an average decrease of 9.9% per quarter
NEGATIVE IMPACT
Price Dip
In the last 1 month, LUNG stock has moved down by -26.5%

About Pulmonx Corp

pulmonx is focused on developing life-changing technologies that improve the lives of patients suffering from lung disease. the company’s first commercial products address emphysema, a form of copd (chronic obstructive pulmonary disease) and the largest unmet medical need in pulmonology. with emphysema, breathing becomes increasingly more difficult as the disease progresses. today in the u.s., advanced emphysema patients have no available alternatives but lung volume reduction surgery, which is associated with high morbidity and mortality, and lung transplantation, which is limited by the availability of donor organs. pulmonx has developed the zephyr endobronchial valve (ebv) therapy, a non-surgical, investigational approach to treating emphysema. the minimally invasive zephyr valve is a tiny, one-way valve designed to reduce the volume of the diseased regions of the lung by blocking airflow, in order to improve breathing and increase activity levels. no surgery is involved in the simp

Organisation	Pulmonx Corp
Headquarters	700 Chesapeake Drive, Redwood City, CA, United States, 94063
Industry	Health Technology
CEO	Mr. Glendon E. French
E-voting on shares	Click here to vote

Key Management of Pulmonx Corp

Name	Title
Mr. Glendon E. French	CEO, President & Director
Mr. David A. Lehman J.D.	General Counsel & Secretary
Ms. Lisa Paul	Chief People Officer
Mr. Jérôme Erath	Senior VP & GM of International
Dr. Derrick Sung Ph.D.	CFO & COO
Mr. Sri Radhakrishnan	Chief Science & Technology Officer
Ms. Marcee M. Maroney	Vice President of Marketing
Mr. Geoffrey Beran Rose	Chief Commercial Officer
Dr. Narinder S. Shargill Ph.D.	Senior Vice President of Global Medical & Clinical Affairs
Mr. John B. McKune	VP of Finance & Corporate Controller

FAQs

What is Pulmonx Corp share price today?

Pulmonx Corp share price today is $1.5 as on February 7, 2026 at 2:29 am IST at the close of the market. Pulmonx Corp share today touched a day high of $1.51 and a low of $1.45.

What is the 52 week high and 52 week low for Pulmonx Corp share?

Pulmonx Corp share touched a 52 week high of $9.37 on February 20, 2025 and a 52 week low of $1.31 on November 20, 2025. Pulmonx Corp stock price today i.e. February 7, 2026 at 2:29 am IST is closed at $1.5,which is 83.99% down from its 52 week high and 14.50% up from its 52 week low.

What is Pulmonx Corp's market capitalisation today?

Pulmonx Corp market capitalisation is $0.00T as on February 7, 2026 at 2:29 am IST.

How to invest in Pulmonx Corp Stock (LUNG) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Pulmonx Corp on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Pulmonx Corp Shares that will get you 1.0000 shares as per Pulmonx Corp share price of $1.5 per share as on February 7, 2026 at 2:29 am IST.

What is the minimum amount required to buy Pulmonx Corp Stock (LUNG) from India?

Indian investors can start investing in Pulmonx Corp (LUNG) shares with as little as ₹90.555 or $1 (as of February 9, 2026 at 6:57 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹905.55 in Pulmonx Corp stock (as per the Rupee-Dollar exchange rate as on February 9, 2026 at 6:57 am IST). Based on Pulmonx Corp share’s latest price of $1.5 as on February 7, 2026 at 2:29 am IST, you will get 6.6667 shares of Pulmonx Corp. Learn more about fractional shares .

What are the returns that Pulmonx Corp has given to Indian investors in the last 5 years?

Pulmonx Corp stock has given -97.51% share price returns and 23.83% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?